IBNSINA PHARMA revenue breakdown overview

IBNSINA PHARMA revenue for the last year amounted to 55.41 B EGP, the most of which — 55.84 B EGP — came from its highest performing source at the moment, Pharmaceutical and Semi-pharmaceutical Products, the year earlier bringing 33.95 B EGP. The greatest contribution to the revenue figure was made by Egypt — last year it brought IBNSINA PHARMA 55.84 B EGP, and the year before that — 33.95 B EGP.